SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (2140)3/26/1999 10:40:00 AM
From: M. Ramle  Read Replies (1) | Respond to of 10280
 
Peter:

Thanks a lot for your very informative analysis. You pretty much covered it all and it does not sound like you missed anything from the interview. Good Luck.

Mazen



To: Biomaven who wrote (2140)3/26/1999 11:23:00 AM
From: sam  Respond to of 10280
 
Thanks Peter. Good work.



To: Biomaven who wrote (2140)3/26/1999 12:24:00 PM
From: Thomas M.  Read Replies (1) | Respond to of 10280
 
Thanks for the great posts. You should write a book on this stock. <g>

Tom



To: Biomaven who wrote (2140)3/26/1999 1:17:00 PM
From: BMcV  Read Replies (1) | Respond to of 10280
 
One more thing that struck me from the CC was that since the current nebulizer Albuterol market is generic, SEPR feels it is something of a gray area as far as salemanship goes, that is, their representatives will be the only ones actively selling into the market.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News